Anticoagulation in Patients With Device-Detected Atrial Fibrillation With and Without a Prior Stroke or Transient Ischemic Attack: The NOAH-AFNET 6 Trial.

Hans-Christoph Diener Nina Fluschnik Susanne Sehner Tobias Toennis Emanuele Bertaglia Carina Blomstrom-Lundqvist Axel Brandes Vincent Beuger Melanie Jane Calvert Alan John Camm Grigoris Chlouverakis Gheorghe Andrei Dan Wolfgang Dichtl Alexander Fierenz Andreas Goette Joris R de Groot Astrid N L Hermans Gregory Yoke Hong Lip Andrzej Lubiński Eloi Marijon Bela Merkely Lluis Mont Julius Nikorowitsch Ann-Kathrin Ozga Kim Rajappan Andrea SarkozyDaniel ScherrRenate B Schnabel Ulrich Schotten Emmanuel N Simantirakis Panos E Vardas Dan Wichterle Antonia Zapf Paulus F Kirchhofnull null

Published in: Journal of the American Heart Association (2024)

Anticoagulation appears to have ambiguous effects in patients with device-detected AF and a prior stroke or TIA in this hypothesis-generating analysis of the NOAH-AFNET 6 in the absence of ECG-documented AF, partially due to a low rate of stroke without anticoagulation.

Keyphrases